Form 4 for BGMS Bio Green Med Solution, Inc.
Accepted 2023-02-02 00:00:00 ET · period of report 2023-01-31 · accession 0001104659-23-009910 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-02 | 2023-01-31 | BGMS | Rombotis Spiro George | Pres, CEO, Dir | A - Grant | $0.00 | +57.6K | 62.6K | +1,155% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-31 | A | A | 57,600 | $0.00 | 62,588 | D | — | — | (F1) The reporting person received an award of 57,600 restricted stock units on January 31, 2023, which shall vest in full on January 31, 2026, provided, however, that if certain clinical milestones are achieved then such restricted stock units shall vest in full earlier in connection with such achievement. (F2) Includes 4,988 shares of common stock and 57,600 restricted stock units. |